Article: Elron Electronic Industries Announces Second Quarter 2009 Results and Signing of a Definitive Agreement for the Sale of Its Holding in Netvision.

* Decrease in Net Loss Attributable to Shareholders in the Second Quarter of 2009 to $4.1 Million, Compared with $16.8 Million in Second Quarter of 2008 and $9.8 Million in First Quarter of 2009

* Decrease of Approximately 58% in Elron's Non-Consolidated G&A Costs in the Second Quarter of 2009 Compared with the Second Quarter of 2008

* Group-Company 3DV Completed Sale of Substantially All Assets to Third Party; Elron Recorded $4.4 Million Gain on Sale

* Group-Company Medingo Received FDA Clearance to Market Its Insulin Micropump in the United States

* Definitive Agreement Signed for the Sale of Holding in Netvision to IDB Group ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!